0001181431-11-049333.txt : 20110914 0001181431-11-049333.hdr.sgml : 20110914 20110914184952 ACCESSION NUMBER: 0001181431-11-049333 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110912 FILED AS OF DATE: 20110914 DATE AS OF CHANGE: 20110914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZUERBLIS KENNETH J CENTRAL INDEX KEY: 0001007923 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 111091426 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE RD CITY: PISCATAWAY STATE: NJ ZIP: 08854 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 3 1 rrd321895.xml FORM 3 X0204 3 2011-09-12 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001007923 ZUERBLIS KENNETH J ONE TOWER CENTER BLVD. 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 EVP, Chief Financial Officer Option to Purchase Common Stock, $.01 par value 3.81 2011-12-12 2021-09-12 Common Stock, $.01 par value per share 300000 D These options vest as to 25,000 shares of the grant at the end of each three-month period following September 12, 2011. /s/ Irina Ishak as Attorney-In-Fact for Kenneth J. Zuerblis 2011-09-14